Shimo T, Yamazaki M, Noguchi Y, Mukawa A, Kato H, Ito Y
J Toxicol Sci. 1982 Jul;7 Suppl 1:1-13. doi: 10.2131/jts.7.supplementi_1.
The skin and eye primary irritation tests, and skin cumulative irritation test were performed on male rabbits, which were topically treated with a volume of 1 g/body of 0.06% and 0.12% dexamethasone valerate (DV-17) ointments as a test drug, and 0.1% hydrocortisone butyrate (HB) and 0.12% betamethasone valerate (BMV) ointments as an active control drug in order to evaluate the topical and systemic effects. No skin and eye primary irritations except minimal skin erythema and slight conjunctival redness were seen in above four corticosteroids. Judging from the results such as skin atrophy, inhibition of body weight gains, and decreases of thymus, spleen and adrenal weights, the potency of toxicities among the four corticosteroid ointments appeared to be as follows: 0.12% DV-17, 0.12% BMV greater than 0.1% HB greater than 0.06% DV-17.
对雄性兔子进行了皮肤和眼原发性刺激试验以及皮肤累积刺激试验,将0.06%和0.12%的戊酸倍他米松(DV-17)软膏作为受试药物,以1 g/只的剂量局部给药,同时将0.1%丁酸氢化可的松(HB)软膏和0.12%戊酸倍他米松(BMV)软膏作为阳性对照药物,以评估局部和全身作用。上述四种皮质类固醇除了引起轻微的皮肤红斑和轻微的结膜发红外,未观察到皮肤和眼原发性刺激。从皮肤萎缩、体重增加抑制以及胸腺、脾脏和肾上腺重量减轻等结果判断,四种皮质类固醇软膏的毒性强度似乎如下:0.12% DV-17、0.12% BMV大于0.1% HB大于0.06% DV-17。